In a pilot randomized controlled trial designed to assess the effects of aerobic exercise in AD (the FIT-AD trial) (Li et al., 2021), baseline plasma NfL levels and the changes observed after 3 months were associated with changes in cognition and the ability to perform activities of daily living. This evidence concerns the gene NEFL and Alzheimer disease.